---
title: "HMGCR"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Genetic Information Analysis Report"
tags: ['HMGCR', 'CholesterolBiosynthesis', 'FamilialHypercholesterolemia', 'StatinTherapy', 'GeneticMutation', 'CardiovascularDisease', 'IschemicStroke', 'MevalonatePathway']
---

## Genetic Information Analysis Report

### Gene: HMGCR

- **Function for gene**: HMGCR (3-Hydroxy-3-Methylglutaryl-CoA Reductase) is involved in the Mevalonate pathway, which is responsible for cholesterol biosynthesis. HMGCR catalyzes the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) to mevalonate.

- **External IDs for gene and genomic location, Aliases**: 
    - HGNC ID: 5006 
    - NCBI Entrez Gene ID: 3156 
    - Ensembl ID: ENSG00000113161 
    - Genomic location: Chromosome 5, 1.1 - 1.4 Mb 
    - Aliases: MLRSA, HMG-CoA reductase, hydroxymethylglutaryl-CoA reductase, 3-hydroxy-3-mthylglutaryl-CoA reductase, L-mevalonate reductase, NBD1

- **External sites**: 
    - HGNC: [Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:5006)
    - NCBI Entrez: [Click](https://www.ncbi.nlm.nih.gov/gene/3156) 
    - Ensembl: [Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000113161;r=5:1561785-1575881)
    - OMIM: [Click](https://omim.org/entry/142910)
    - UniProtKB/Swiss-Prot: [Click](https://www.uniprot.org/uniprot/P04035)

- **AA mutation list and mutation type with dbSNP ID**: 
    - c.1162G>A (rs17238540)
    - c.338T>C (rs17238484)
    - c.793C>T (rs17244879)
    - c.832A>G (rs11887534)

- **Somatic SNVs/InDels with dbSNP ID**: None identified.

- **Related disease**: Mutations in HMGCR have been associated with autosomal dominant familial hypercholesterolemia, a condition characterized by high blood cholesterol levels and early onset of cardiovascular disease.

- **Treatment and prognosis**: Treatment options for individuals with familial hypercholesterolemia include statins, which inhibit HMGCR and reduce cholesterol levels. Prognosis depends on the severity of the condition and the effectiveness of treatment.

- **Drug response**: Response to statin therapy may vary depending on the specific mutation in HMGCR.

- This report was generated by an automated Genetic Information Analysis program. Please reach out to [ADD CONTACT EMAIL] for questions or concerns regarding the report.

- **References**:
    - Zhang L, Guo XX, Zhang ZL, Xu J, Kou JP, Peng M, Qin MJ, Han Y, Jiang Y. Association of HMGCR Gene Polymorphisms with the Risk of Ischemic Stroke in a Chinese Han Population. J Mol Neurosci. 2016 Aug;59(4):542-9. doi: 10.1007/s12031-016-0798-z. Epub 2016 Jun 30. PMID: 27364611.
    - Moussa K, Berberich AJ, Li TS, Frishman WH. Statins: an update on potential therapeutic uses. Cardiol Rev. 2001 Mar-Apr;9(2):73-89. doi: 10.1097/00045415-200103000-00002. PMID: 11176310.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**